Cases 1 - 10 of 10
Biogen International GmbH et al v. TWi Pharmaceuticals, Inc. et al
as 1:2017cv00856
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
TWi Pharmaceuticals, Inc. and TWi Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Amneal Pharmaceuticals LLC et al.
as 1:2017cv00823
Defendant:
TWi Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sawai Pharmaceutical Co., Ltd. and others
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Cause Of Action: 35 U.S.C. § 271
Eli Lilly and Company et al v. TWi Pharmaceuticals, Inc. et al
as 1:2017cv00174
Plaintiff:
Eli Lilly and Company , Eli Lilly Export S.A. and Acrux DDS Pty Ltd.
Defendant:
TWi Pharmaceuticals, Inc. and TWi Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Unimed Pharmaceuticals, LLC et al v. TWi Pharmaceuticals, Inc.
as 1:2016cv00810
Plaintiff:
Unimed Pharmaceuticals, LLC , Besins Healthcare Inc. and Besins Healthcare Luxembourg SARL
Defendant:
TWi Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Allergan, Inc. v. TWi Pharmaceuticals, Inc. et al
as 1:2016cv00620
Plaintiff:
Allergan, Inc.
Defendant:
TWi Pharmaceuticals, Inc. and TWi Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Par Pharmaceutical, Inc. et al v. TWi Pharmaceuticals, Inc. et al
as 1:2015cv00710
Plaintiff:
Par Pharmaceutical, Inc. and Alkermes Pharma Ireland Limited
Defendant:
TWi Pharmaceuticals, Inc. and TWi Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. TWi Pharmaceuticals, Inc. et al
as 1:2015cv00698
Plaintiff:
Par Pharmaceutical, Inc. and Alkermes Pharma Ireland Limited
Defendant:
TWi Pharmaceuticals, Inc. and TWi Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical Inc. et al v. Breckenridge Pharmaceutical Inc. et al
as 1:2015cv00486
Plaintiff:
Par Pharmaceutical Inc. and Alkermes Pharma Ireland Limited
Defendant:
Breckenridge Pharmaceutical Inc., TWi Pharmaceuticals Inc. and TWi Pharmaceuticals USA Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Aptalis Pharma, Inc. et al
as 1:2012mc00234
Movant:
TWi Pharmaceuticals Inc.
Respondent:
Aptalis Pharma, Inc. and Aptalis Holdings Inc.
Cause Of Action: Motion to Compel
Endo Pharmaceuticals Inc. et al v. TWi Pharmaceuticals Inc. et al
as 1:2012cv00848
Plaintiff:
Endo Pharmaceuticals Inc. , Teikoku Pharma USA Inc. and Teikoku Seiyaku Co Ltd.
Defendant:
TWi Pharmaceuticals Inc. and Teh Seng Pharmaceutical Mfg. Co. Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
